A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease

被引:33
作者
Roberts, Patrick [1 ,2 ]
Spiros, Athan [1 ]
Geerts, Hugo [1 ,3 ]
机构
[1] In Silico Biosci, Berwyn, PA USA
[2] Washington State Univ, Vancouver, WA USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源
FRONTIERS IN PHARMACOLOGY | 2016年 / 7卷
关键词
Parkinson's disease; systems pharmacology; drug treatment; DEEP BRAIN-STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; LEVODOPA-INDUCED DYSKINESIAS; THALAMIC RELAY NEURONS; SUBTHALAMIC NUCLEUS; DRUG DISCOVERY; COMPUTER-MODEL; L-DOPA; ELECTROPHYSIOLOGICAL PROPERTIES; PYRAMIDAL NEURONS;
D O I
10.3389/fphar.2016.00006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The current treatment of Parkinson's disease with dopamine-centric approaches such as L-DOPA and dopamine agonists, although very successful, is in need of alternative treatment strategies, both in terms of disease modification and symptom management. Various non-dopaminergic treatment approaches did not result in a clear clinical benefit, despite showing a clear effect in preclinical animal models. In addition, polypharmacy is common, sometimes leading to unintended effects on non motor cognitive and psychiatric symptoms. To explore novel targets for symptomatic treatment and possible synergistic pharmacodynamic effects between different drugs, we developed a computer-based Quantitative Systems Pharmacology (QSP) platform of the closed cortico-striatal-thalamic-cortical basal ganglia loop of the dorsal motor circuit. This mechanism-based simulation platform is based on the known neuroanatomy and neurophysiology of the basal ganglia and explicitly incorporates domain expertise in a formalized way. The calculated beta/gamma power ratio of the local field potential in the subthalamic nucleus correlates well (R-2 = 0.71) with clinically observed extra-pyramidal symptoms triggered by antipsychotics during schizophrenia treatment (43 drug-dose combinations). When incorporating Parkinsonian (PD) pathology and reported compensatory changes, the computer model suggests a major increase in b/g ratio (corresponding to bradykinesia and rigidity) from a dopamine depletion of 70% onward. The correlation between the outcome of the QSP model and the reported changes in UPDRS III Motor Part for 22 placebo-normalized drug-dose combinations is R-2 = 0.84. The model also correctly recapitulates the lack of clinical benefit for perampanel, MK-0567 and flupirtine and offers a hypothesis for the translational disconnect. Finally, using human PET imaging studies with placebo response, the computer model predicts well the placebo response for chronic treatment, but not for acute treatment in PD.
引用
收藏
页数:14
相关论文
共 78 条
[11]   An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers [J].
Brooks, David J. ;
Papapetropoulos, Spyridon ;
Vandenhende, Francois ;
Tomic, Davorka ;
He, Ping ;
Coppell, Alex ;
O'Neill, Gilmore .
CLINICAL NEUROPHARMACOLOGY, 2010, 33 (02) :55-60
[12]   CB1 cannabinoid receptor signalling in Parkinson's disease [J].
Brotchie, JM .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) :54-61
[13]   Translational Bioinformatics: Data-driven Drug Discovery and Development [J].
Butte, A. J. ;
Ito, S. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (06) :949-952
[14]   5-HT excites globus pallidus neurons by multiple receptor mechanisms [J].
Chen, L. ;
Yung, K. K. L. ;
Chan, Y. S. ;
Yung, W. H. .
NEUROSCIENCE, 2008, 151 (02) :439-451
[15]   Activation of NMDA receptors in rat dentate gyrus granule cells by spontaneous and evoked transmitter release [J].
Dalby, NO ;
Mody, I .
JOURNAL OF NEUROPHYSIOLOGY, 2003, 90 (02) :786-797
[16]   Fluctuating synaptic conductances recreate in vivo-like activity in neocortical neurons [J].
Destexhe, A ;
Rudolph, M ;
Fellous, JM ;
Sejnowski, TJ .
NEUROSCIENCE, 2001, 107 (01) :13-24
[17]   OSCILLATIONS, COMPLEX SPATIOTEMPORAL BEHAVIOR, AND INFORMATION TRANSPORT IN NETWORKS OF EXCITATORY AND INHIBITORY NEURONS [J].
DESTEXHE, A .
PHYSICAL REVIEW E, 1994, 50 (02) :1594-1606
[18]  
Destexhe A, 1998, J NEUROPHYSIOL, V79, P999
[19]  
Werneck ALD, 2009, ARQ NEURO-PSIQUIAT, V67, P407, DOI 10.1590/S0004-282X2009000300007
[20]   Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture [J].
Falk, T ;
Zhang, SL ;
Erbe, EL ;
Sherman, SJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 2006, 494 (02) :275-289